Publications by authors named "Ryo Saji"

Claim this Profile
C
Coxsackie and adenovirus receptor is a novel regulator of inflammatory response in endotoxin-induced failing heart.
Reo Matsumura, Mototsugu Nishii, Haruya Usuku, Masahiro Nakayama, Masaki Hachisuka, Ryo Saji

J Mol Cell Cardiol Plus· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining blood glucose and SpO/FiO ratio facilitates prediction of imminent ventilatory needs in emergency room COVID-19 patients.
Kazuya Sakai, Kai Okoda, Mototsugu Nishii, Ryo Saji, Fumihiro Ogawa

Sci Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of dual-energy computed tomography in the association of COVID-19 pneumonia severity.
Takahiro Michishita, Ryo Saji, Hiroshi Miyazaki, Sena Mishima, Kosuke Shimada

Acute Med Surg· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach.
Yayoi Kimura, Yusuke Nakai, Jihye Shin, Miyui Hara, Yuriko Takeda, Ryo Saji

Sci Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin-E2 receptor-4 stimulant rescues cardiac malfunction during myocarditis and protects the heart from adverse ventricular remodeling after myocarditis.
Akira Takakuma, Mototsugu Nishii, Alan Valaperti, Haruto Hiraga, Ryo Saji

Sci Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19.
Ryo Saji, Mototsugu Nishii, Kazuya Sakai, Kei Miyakawa, Yutaro Yamaoka

PLoS One· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19.
Fumihiro Ogawa, Yasufumi Oi, Kento Nakajima, Reo Matsumura, Tomoki Nakagawa, Ryo Saji

Thromb J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 May Cause False-Positive Results in Serological Assays.
Yutaro Yamaoka, Sundararaj S Jeremiah, Kei Miyakawa, Ryo Saji, Mototsugu Nishii

Clin Infect Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality.
Kento Nakajima, Takeru Abe, Ryo Saji, Fumihiro Ogawa, Hayato Taniguchi

J Infect· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles.
Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Norihisa Ohtake, Satoko Matsunaga, Yutaro Yamaoka, Ryo Saji

J Mol Cell Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis